Survival in the United Kingdom Medical Research Council AML trials 1970–1999 for patients aged 15–59 years.
Lukemia powerpoint
Treatment of lupus nephritis in adult patients
R DEVELOPMENT PROGRAM & STUDY RESULTS Slide # 31.
APL Pierre Fenaux (Hopital Avicenne,Paris 13 University)
Friday, April 11, 2014 Irene M Ghobrial, MD Dana-Farber/Harvard Cancer Center Ola Landgren, MD, PhD Center for Cancer Research National Cancer Institute.
FOLFOXIRI/ bevacizumab ( bev ) versus FOLFIRI/ bev as first-line treatment in unresectable metastatic
Colorectal Cancer: What Next? Neal J. Meropol, MD Chief, Hematology and Oncology University Hospitals Case Medical Center Case Western Reserve University.
Childhood Leukemia Mary E. MacBlane MS, PNP-BC. Goals Incidence Etiology Diagnosis Types/Classification Treatment Primary Care Pearls.
